Pub Date : 2024-07-11DOI: 10.20517/2574-1209.2023.140
Canqui Flores Bernabe, Romel P. Melgarejo-Bolivar, Alfredo Tumi-Figueroa, S. Thirukumaran, G. M. Devi, Sudhakar Sengan
Aim: A significant medical diagnostic tool for monitoring cardiovascular health and function is 2D electrocardiograms. For computerized echocardiogram (echo) analysis, recognizing how this device performs is essential. This paper primarily focuses on detecting the transducer's viewpoint in cardiac echo videos using spatiotemporal data. It distinguishes between different viewpoints by monitoring the heart's function and rate throughout the cycle of heartbeats. Computer-aided diagnosis (CAD) examination sizes are the first steps toward computerized classification of cardiac imaging tests. Since clinical analysis frequently starts with automatic classification, the current view can enhance the detection of Cardiac Vascular Disease (CVD). Methods: This research article uses a Machine Learning (ML) algorithm called the Integrated Metaheuristic Technique (IMT), which is the Whale Optimization Algorithm with Weighted Support Vector Machine (WOA-WSVM). Results: The parameters in the classification are optimized with the assistance of WOA, and the echo is classified using WSVM. The WOA-WSVM classifies the images effectively and achieves an accuracy of 98.4%. Conclusion: The numerical analysis states that the WOA-WSVM technique outperforms the existing state-of-the-art algorithms.
{"title":"Echocardiographic cardiac views classification using whale optimization and weighted support vector machine","authors":"Canqui Flores Bernabe, Romel P. Melgarejo-Bolivar, Alfredo Tumi-Figueroa, S. Thirukumaran, G. M. Devi, Sudhakar Sengan","doi":"10.20517/2574-1209.2023.140","DOIUrl":"https://doi.org/10.20517/2574-1209.2023.140","url":null,"abstract":"Aim: A significant medical diagnostic tool for monitoring cardiovascular health and function is 2D electrocardiograms. For computerized echocardiogram (echo) analysis, recognizing how this device performs is essential. This paper primarily focuses on detecting the transducer's viewpoint in cardiac echo videos using spatiotemporal data. It distinguishes between different viewpoints by monitoring the heart's function and rate throughout the cycle of heartbeats. Computer-aided diagnosis (CAD) examination sizes are the first steps toward computerized classification of cardiac imaging tests. Since clinical analysis frequently starts with automatic classification, the current view can enhance the detection of Cardiac Vascular Disease (CVD).\u0000 Methods: This research article uses a Machine Learning (ML) algorithm called the Integrated Metaheuristic Technique (IMT), which is the Whale Optimization Algorithm with Weighted Support Vector Machine (WOA-WSVM).\u0000 Results: The parameters in the classification are optimized with the assistance of WOA, and the echo is classified using WSVM. The WOA-WSVM classifies the images effectively and achieves an accuracy of 98.4%.\u0000 Conclusion: The numerical analysis states that the WOA-WSVM technique outperforms the existing state-of-the-art algorithms.","PeriodicalId":75299,"journal":{"name":"Vessel plus","volume":"80 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141655563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diabetic kidney disease (DKD) is a global health burden and the leading cause of end-stage renal disease. Its clinical management focuses on controlling hyperglycemia, hypertension, and hyperlipidemia. While the progression of DKD can be slowed with intervention, it cannot be stopped or reversed yet. The pathogenesis of DKD is complex, with an interplay of numerous signaling pathways, and research continues to decipher the players and their role, be it beneficial or pathogenic. Inflammation is an essential defense of our bodies against internal or external insults. The injuries that trigger inflammation range from pathogenic infections and wounds to dysregulated metabolism. Inflammation is helpful only if it is controlled and subsides after it has helped defend the individual against the insult. Uncontrolled or chronic inflammation is recognized as a contributor to numerous chronic diseases. Dysregulated inflammation plays a role in multiple aspects of DKD: glomerular hyperfiltration, mesangial expansion, podocyte injury, tubular injury, basement membrane thickening, fibrosis, and scarring. Since inflammation plays an integral role in the progression of DKD, targeting it for therapy is also reasonable. There is a growing trend of targeting inflammation as a therapeutic approach, with new targets being discovered and evaluated drugs every year. The exponential increase in literature necessitates a comprehensive summary of current information, hence this review.
{"title":"Role of inflammation in the progression of diabetic kidney disease","authors":"Arunita Chatterjee, Jacqueline Tumarin, Sharma Prabhakar","doi":"10.20517/2574-1209.2024.21","DOIUrl":"https://doi.org/10.20517/2574-1209.2024.21","url":null,"abstract":"Diabetic kidney disease (DKD) is a global health burden and the leading cause of end-stage renal disease. Its clinical management focuses on controlling hyperglycemia, hypertension, and hyperlipidemia. While the progression of DKD can be slowed with intervention, it cannot be stopped or reversed yet. The pathogenesis of DKD is complex, with an interplay of numerous signaling pathways, and research continues to decipher the players and their role, be it beneficial or pathogenic. Inflammation is an essential defense of our bodies against internal or external insults. The injuries that trigger inflammation range from pathogenic infections and wounds to dysregulated metabolism. Inflammation is helpful only if it is controlled and subsides after it has helped defend the individual against the insult. Uncontrolled or chronic inflammation is recognized as a contributor to numerous chronic diseases. Dysregulated inflammation plays a role in multiple aspects of DKD: glomerular hyperfiltration, mesangial expansion, podocyte injury, tubular injury, basement membrane thickening, fibrosis, and scarring. Since inflammation plays an integral role in the progression of DKD, targeting it for therapy is also reasonable. There is a growing trend of targeting inflammation as a therapeutic approach, with new targets being discovered and evaluated drugs every year. The exponential increase in literature necessitates a comprehensive summary of current information, hence this review.","PeriodicalId":75299,"journal":{"name":"Vessel plus","volume":"76 20","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141658076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-11DOI: 10.20517/2574-1209.2024.05
Gabriela Sabolová, L. Kočan, Miroslava Rabajdová, S. Rapčanová, Janka Vašková
The study is focused on the connection between cognitive dysfunction, inflammatory processes, oxidative stress, and various associated biological factors. Postoperative cognitive dysfunction is a condition where a patient exhibits a temporary deterioration in cognitive function after surgery, which may include problems with memory, concentration, and overall cognitive performance. While most common among elderly patients, it can occur in individuals of any age. The causes are not fully elucidated, but it is assumed that peripheral trauma during long-term surgical interventions is behind the development of inflammation and the creation of conditions of oxidative stress, which leads to the disruption of the blood-brain barrier and the subsequent development of cognitive impairment. This review aims to describe the detected changes at the level of selected markers of inflammation and oxidative damage in patients, primarily in connection with cardiac surgery.
{"title":"Association of inflammation, oxidative stress, and deteriorated cognitive functions in patients after cardiac surgery","authors":"Gabriela Sabolová, L. Kočan, Miroslava Rabajdová, S. Rapčanová, Janka Vašková","doi":"10.20517/2574-1209.2024.05","DOIUrl":"https://doi.org/10.20517/2574-1209.2024.05","url":null,"abstract":"The study is focused on the connection between cognitive dysfunction, inflammatory processes, oxidative stress, and various associated biological factors. Postoperative cognitive dysfunction is a condition where a patient exhibits a temporary deterioration in cognitive function after surgery, which may include problems with memory, concentration, and overall cognitive performance. While most common among elderly patients, it can occur in individuals of any age. The causes are not fully elucidated, but it is assumed that peripheral trauma during long-term surgical interventions is behind the development of inflammation and the creation of conditions of oxidative stress, which leads to the disruption of the blood-brain barrier and the subsequent development of cognitive impairment. This review aims to describe the detected changes at the level of selected markers of inflammation and oxidative damage in patients, primarily in connection with cardiac surgery.","PeriodicalId":75299,"journal":{"name":"Vessel plus","volume":"14 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141656177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-23DOI: 10.20517/2574-1209.2023.138
Antonella Tommasino, Federico Dell’Aquila, Vincenzo Cesario, Federica Tempestini, Matteo Casenghi, F. Giovannelli, Stefano Rigattieri, Emanuele Barbato, Andrea Berni
Patients who present with acute myocardial infarction (AMI) often suffer from coronary multivessel disease (MVD). This condition is associated with an increased mortality rate; it is, therefore, important to improve clinical outcomes through appropriate treatment strategies. Over the past decades, extensive research in AMI and MVD patients has consistently shown that complete revascularization is superior to treatment of the only culprit lesion. Another controversial issue concerns the most appropriate timing for percutaneous coronary intervention in non-culprit lesions. Fractional flow reserve (FFR) is considered the best method for identifying ischemic coronary lesions in the context of acute coronary syndromes, but the detection of vulnerable plaques in non-culprit vessels could further improve clinical outcomes. Intravascular imaging goes beyond physiology and it is potentially useful to recognize patients who are vulnerable, despite negative FFR. Therefore, we analyzed the most relevant studies that have investigated the relationship between physiological indexes and plaque vulnerability. However, ongoing trials aim to clarify how coronary physiology can be combined with the benefits of intracoronary imaging.
{"title":"Multivessel disease in patient with acute myocardial infarction: current treatment strategies and future perspectives","authors":"Antonella Tommasino, Federico Dell’Aquila, Vincenzo Cesario, Federica Tempestini, Matteo Casenghi, F. Giovannelli, Stefano Rigattieri, Emanuele Barbato, Andrea Berni","doi":"10.20517/2574-1209.2023.138","DOIUrl":"https://doi.org/10.20517/2574-1209.2023.138","url":null,"abstract":"Patients who present with acute myocardial infarction (AMI) often suffer from coronary multivessel disease (MVD). This condition is associated with an increased mortality rate; it is, therefore, important to improve clinical outcomes through appropriate treatment strategies. Over the past decades, extensive research in AMI and MVD patients has consistently shown that complete revascularization is superior to treatment of the only culprit lesion. Another controversial issue concerns the most appropriate timing for percutaneous coronary intervention in non-culprit lesions. Fractional flow reserve (FFR) is considered the best method for identifying ischemic coronary lesions in the context of acute coronary syndromes, but the detection of vulnerable plaques in non-culprit vessels could further improve clinical outcomes. Intravascular imaging goes beyond physiology and it is potentially useful to recognize patients who are vulnerable, despite negative FFR. Therefore, we analyzed the most relevant studies that have investigated the relationship between physiological indexes and plaque vulnerability. However, ongoing trials aim to clarify how coronary physiology can be combined with the benefits of intracoronary imaging.","PeriodicalId":75299,"journal":{"name":"Vessel plus","volume":"39 16","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141108020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-20DOI: 10.20517/2574-1209.2023.147
Thomas V. Bilfinge, G. H. Almassi, A. L. W. Shroyer
The following is a brief review and commentary covering the content of the Special Issue of Vessel Plus entitled Current state of knowledge: Atrial Fibrillation and Cardiac Surgery. All articles in this issue are highlighted with a brief comment for the busy reader, the idea being to facilitate and encourage reading of the original work.
{"title":"Editorial review: guidance for future atrial fibrillation research","authors":"Thomas V. Bilfinge, G. H. Almassi, A. L. W. Shroyer","doi":"10.20517/2574-1209.2023.147","DOIUrl":"https://doi.org/10.20517/2574-1209.2023.147","url":null,"abstract":"The following is a brief review and commentary covering the content of the Special Issue of Vessel Plus entitled Current state of knowledge: Atrial Fibrillation and Cardiac Surgery. All articles in this issue are highlighted with a brief comment for the busy reader, the idea being to facilitate and encourage reading of the original work.","PeriodicalId":75299,"journal":{"name":"Vessel plus","volume":"35 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141122128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-25DOI: 10.20517/2574-1209.2023.126
A. Browne, André Lamy
This narrative review summarizes the angiographic and clinical outcome results of the most common coronary artery bypass grafting (CABG) conduits. The left internal mammary artery is the preferred first conduit to bypass the left anterior descending artery due to superior long-term survival and graft patency. Recent studies suggest the radial artery may be the preferred second conduit for the circumflex or right coronary artery territories, challenging the belief that the right internal mammary artery is the best choice. Despite their historical high failure rates, saphenous vein grafts continue to be widely used as secondary conduits. Several recent studies report suboptimal rates of right internal mammary artery graft failure, with clinical outcomes comparable to or worse than saphenous veins. The suboptimal rates of RIMA graft failure may be attributed to several factors such as improvements in vein graft failure rates, the use of in situ and non-left anterior descending artery grafting configurations, and skeletonized harvesting techniques. While observational studies favor multiple over single arterial grafting, randomized studies are needed for confirmation. The ongoing Randomized comparison of the clinical Outcome of single vs. Multiple Arterial grafts (ROMA) trial aims to determine if multiple arterial grafting reduces major adverse cardiovascular events and mortality and how secondary conduit selection influences these outcomes. Greater adoption of arterial grafting strategies is likely to come from high-quality evidence of benefit and safety from ongoing and future large pragmatic trials.
{"title":"Selecting conduits for coronary artery bypass grafting: caution regarding the right internal mammary artery","authors":"A. Browne, André Lamy","doi":"10.20517/2574-1209.2023.126","DOIUrl":"https://doi.org/10.20517/2574-1209.2023.126","url":null,"abstract":"This narrative review summarizes the angiographic and clinical outcome results of the most common coronary artery bypass grafting (CABG) conduits. The left internal mammary artery is the preferred first conduit to bypass the left anterior descending artery due to superior long-term survival and graft patency. Recent studies suggest the radial artery may be the preferred second conduit for the circumflex or right coronary artery territories, challenging the belief that the right internal mammary artery is the best choice. Despite their historical high failure rates, saphenous vein grafts continue to be widely used as secondary conduits. Several recent studies report suboptimal rates of right internal mammary artery graft failure, with clinical outcomes comparable to or worse than saphenous veins. The suboptimal rates of RIMA graft failure may be attributed to several factors such as improvements in vein graft failure rates, the use of in situ and non-left anterior descending artery grafting configurations, and skeletonized harvesting techniques. While observational studies favor multiple over single arterial grafting, randomized studies are needed for confirmation. The ongoing Randomized comparison of the clinical Outcome of single vs. Multiple Arterial grafts (ROMA) trial aims to determine if multiple arterial grafting reduces major adverse cardiovascular events and mortality and how secondary conduit selection influences these outcomes. Greater adoption of arterial grafting strategies is likely to come from high-quality evidence of benefit and safety from ongoing and future large pragmatic trials.","PeriodicalId":75299,"journal":{"name":"Vessel plus","volume":"19 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140653578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-08DOI: 10.20517/2574-1209.2023.135
Chan Joon Kim, Katherine Godfrey, Swagata Patnaik, Roxana Mehran
Cardiovascular disease is the leading cause of death worldwide. Over past decades, multiple clinical trials have provided substantial evidence supporting the advantages of managing plasma lipids in individuals with coronary artery disease (CAD). A primary focus in reducing clinical atherosclerotic cardiovascular disease (ASCVD) in patients who have undergone percutaneous coronary intervention (PCI) is the regulation of blood lipids, with an emphasis on low-density lipoprotein (LDL) cholesterol. Statins represent the cornerstone of lipid-lowering therapy (LLT), with high-intensity statins consistently associated with beneficial outcomes in patients at high risk of ASCVD. Nevertheless, a notable portion of patients do not achieve their target cholesterol levels through statin monotherapy, necessitating the inclusion of complementary LLT strategies. Among these therapies are ezetimibe and proprotein convertase subtilisin/kexin type 9 inhibitors, which have also demonstrated clinical advantages by further reducing cholesterol levels. Existing guidelines recommend using these agents when maximally tolerated statin doses fall short of achieving target LDL levels. Additionally, recently introduced ATP-citrate lyase inhibitors, such as bempedoic acid, have gained approval as adjunctive treatments. Furthermore, icosapent ethyl, a purified derivative of eicosapentaenoic acid, targets hypertriglyceridemia and has shown cardiovascular benefits compared to placebo. In this article, we delve into the mechanisms of blood lipids and molecular targets in connection with CAD undergoing PCI. We also explore the current landscape of available LLT options, guidelines in practice, and the subtleties of therapy.
心血管疾病是导致全球死亡的主要原因。在过去的几十年中，多项临床试验提供了大量证据，证明对冠状动脉疾病（CAD）患者进行血浆血脂管理具有优势。在接受经皮冠状动脉介入治疗（PCI）的患者中，减少临床动脉粥样硬化性心血管疾病（ASCVD）的一个主要重点是调节血脂，重点是低密度脂蛋白（LDL）胆固醇。他汀类药物是降脂疗法（LLT）的基石，高强度他汀类药物对 ASCVD 高风险患者的疗效一直很好。尽管如此，仍有相当一部分患者无法通过他汀类药物单一疗法达到目标胆固醇水平，因此有必要纳入辅助性 LLT 策略。这些疗法包括依折麦布和9型丙蛋白转化酶(proprotein convertase subtilisin/kexin type 9)抑制剂，它们通过进一步降低胆固醇水平也显示出了临床优势。当他汀类药物的最大耐受剂量无法达到目标低密度脂蛋白水平时，现有指南建议使用这些药物。此外，最近推出的 ATP 柠檬酸溶解酶抑制剂（如贝门冬氨酸）已被批准作为辅助治疗药物。此外，二十碳五烯酸的纯化衍生物 icosapent ethyl 针对高甘油三酯血症，与安慰剂相比对心血管有益。在本文中，我们将深入探讨与接受 PCI 治疗的 CAD 相关的血脂机制和分子靶点。我们还探讨了目前可用的 LLT 选择、实践指南和治疗的微妙之处。
{"title":"Lipid-lowering therapies in patients undergoing percutaneous coronary intervention","authors":"Chan Joon Kim, Katherine Godfrey, Swagata Patnaik, Roxana Mehran","doi":"10.20517/2574-1209.2023.135","DOIUrl":"https://doi.org/10.20517/2574-1209.2023.135","url":null,"abstract":"Cardiovascular disease is the leading cause of death worldwide. Over past decades, multiple clinical trials have provided substantial evidence supporting the advantages of managing plasma lipids in individuals with coronary artery disease (CAD). A primary focus in reducing clinical atherosclerotic cardiovascular disease (ASCVD) in patients who have undergone percutaneous coronary intervention (PCI) is the regulation of blood lipids, with an emphasis on low-density lipoprotein (LDL) cholesterol. Statins represent the cornerstone of lipid-lowering therapy (LLT), with high-intensity statins consistently associated with beneficial outcomes in patients at high risk of ASCVD. Nevertheless, a notable portion of patients do not achieve their target cholesterol levels through statin monotherapy, necessitating the inclusion of complementary LLT strategies. Among these therapies are ezetimibe and proprotein convertase subtilisin/kexin type 9 inhibitors, which have also demonstrated clinical advantages by further reducing cholesterol levels. Existing guidelines recommend using these agents when maximally tolerated statin doses fall short of achieving target LDL levels. Additionally, recently introduced ATP-citrate lyase inhibitors, such as bempedoic acid, have gained approval as adjunctive treatments. Furthermore, icosapent ethyl, a purified derivative of eicosapentaenoic acid, targets hypertriglyceridemia and has shown cardiovascular benefits compared to placebo. In this article, we delve into the mechanisms of blood lipids and molecular targets in connection with CAD undergoing PCI. We also explore the current landscape of available LLT options, guidelines in practice, and the subtleties of therapy.","PeriodicalId":75299,"journal":{"name":"Vessel plus","volume":"138 S251","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140731583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-29DOI: 10.20517/2574-1209.2023.125
Gatr-alnada Gheriani, Petar S. Lenert
Systemic vasculitides can cause a wide variety of gastrointestinal manifestations (GI) ranging from mild and frequently nonspecific abdominal pains to potentially life-threatening bowel perforations. Vascular involvement in systemic vasculitides can affect any GI blood vessel, most commonly mesenteric, hepatic, or splenic arteries. Inflammatory changes affecting different layers of arterial vessel walls can lead to aneurysmatic dilatation or blood vessel occlusion with subsequent organ ischemia leading to mucosal ulcerations, GI bleeding, perforations, or bowel obstruction. While the presence of extraintestinal manifestations may aid in diagnosis, delays in making appropriate diagnoses and rapid initiation of glucocorticoid and immunosuppressive treatment can have detrimental consequences. Awareness of isolated gastrointestinal vasculitis is of particular importance as it frequently remains undiagnosed until end-stage organ damage becomes apparent. Vasculitis mimics such as vascular Ehlers-Danlos syndrome or fibromuscular dysplasia add another lay of complexity in approaching patients with suspected GI vasculitis and should always be carefully considered.
{"title":"Abdominal involvement as a primary manifestation of systemic or isolated gastrointestinal vasculitis","authors":"Gatr-alnada Gheriani, Petar S. Lenert","doi":"10.20517/2574-1209.2023.125","DOIUrl":"https://doi.org/10.20517/2574-1209.2023.125","url":null,"abstract":"Systemic vasculitides can cause a wide variety of gastrointestinal manifestations (GI) ranging from mild and frequently nonspecific abdominal pains to potentially life-threatening bowel perforations. Vascular involvement in systemic vasculitides can affect any GI blood vessel, most commonly mesenteric, hepatic, or splenic arteries. Inflammatory changes affecting different layers of arterial vessel walls can lead to aneurysmatic dilatation or blood vessel occlusion with subsequent organ ischemia leading to mucosal ulcerations, GI bleeding, perforations, or bowel obstruction. While the presence of extraintestinal manifestations may aid in diagnosis, delays in making appropriate diagnoses and rapid initiation of glucocorticoid and immunosuppressive treatment can have detrimental consequences. Awareness of isolated gastrointestinal vasculitis is of particular importance as it frequently remains undiagnosed until end-stage organ damage becomes apparent. Vasculitis mimics such as vascular Ehlers-Danlos syndrome or fibromuscular dysplasia add another lay of complexity in approaching patients with suspected GI vasculitis and should always be carefully considered.","PeriodicalId":75299,"journal":{"name":"Vessel plus","volume":"78 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140366564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-21DOI: 10.20517/2574-1209.2023.48
Tim Somers, Wilson W. L. Li, J. Jongenotter, Michel W. Verkroost, A. F. Verhagen, Wim J. Morshuis, Tim Smith, Guillaume S. C. Geuzebroek, R. Heijmen
Aim: Optimal cannulation strategy for acute type A aortic dissection (ATAAD) surgery remains debated. Recent guidelines have advocated antegrade systemic perfusion through right axillary artery (RAX) cannulation, instead of femoral artery (FA) cannulation. However, RAX cannulation can be technically challenging and time-consuming. On the other hand, direct (ascending) aorta (DA) cannulation is a swift procedure that also ensures downstream antegrade flow. In this regard, we assessed whether DA cannulation is a safe alternative to FA cannulation. Methods: Records of all patients undergoing ATAAD surgery between 2006-2022 at the Radboud University Medical Center were retrospectively reviewed. Results: In total, 281 patients underwent surgery for ATAAD during the investigated period. Three patients were excluded due to death before the start of extracorporeal circulation and four because of RAX cannulation. Of the remaining 274 patients, 53% (N = 145) received primary FA and 47% (N = 129) DA cannulation, with a success rate of 98% for both approaches. Surgical mortality (combined in-hospital and 30-day) was 9.9% (7.8% DA group vs. 11.7% FA group, P = 0.271). New permanent neurological damage was seen in 10.9% vs. 6.9% (P = 0.248), respectively. In multivariate analysis, cannulation strategies were not significantly associated with surgical mortality nor postoperative new permanent neurological damage. Conclusion: DA cannulation offers a safe and fast alternative to FA cannulation in ATAAD surgery. There were no significant differences in mortality and neurological complications. Future studies should focus on the differences between RAX and DA cannulation strategies on postoperative outcomes in ATAAD surgery.
目的：急性 A 型主动脉夹层（ATAAD）手术的最佳插管策略仍存在争议。最近的指南提倡通过右腋动脉（RAX）插管进行前向全身灌注，而不是股动脉（FA）插管。然而，RAX 插管在技术上具有挑战性，而且耗时较长。另一方面，直接（升）主动脉（DA）插管是一种快速的手术，也能确保下游逆行血流。为此，我们评估了 DA 插管是否是 FA 插管的安全替代方案。方法：回顾性审查了 2006-2022 年间在拉德布德大学医学中心接受 ATAAD 手术的所有患者的记录。结果：在调查期间，共有 281 名患者接受了 ATAAD 手术。其中有3名患者因在体外循环开始前死亡而被排除，4名患者因RAX插管而被排除。在剩余的 274 名患者中，53%（145 人）接受了初级 FA，47%（129 人）接受了 DA 插管，两种方法的成功率均为 98%。手术死亡率（院内死亡率和 30 天死亡率之和）为 9.9%（DA 组 7.8% 对 FA 组 11.7%，P = 0.271）。出现新的永久性神经损伤的比例分别为 10.9% 对 6.9%（P = 0.248）。在多变量分析中，插管策略与手术死亡率和术后新的永久性神经损伤无明显关联。结论在ATAAD手术中，DA插管是FA插管的一种安全、快速的替代方案。死亡率和神经系统并发症没有明显差异。未来的研究应重点关注RAX和DA插管策略对ATAAD手术术后结果的影响。
{"title":"Direct aortic cannulation, a safe alternative to femoral artery cannulation - 17 years of type A dissection surgery experience","authors":"Tim Somers, Wilson W. L. Li, J. Jongenotter, Michel W. Verkroost, A. F. Verhagen, Wim J. Morshuis, Tim Smith, Guillaume S. C. Geuzebroek, R. Heijmen","doi":"10.20517/2574-1209.2023.48","DOIUrl":"https://doi.org/10.20517/2574-1209.2023.48","url":null,"abstract":"Aim: Optimal cannulation strategy for acute type A aortic dissection (ATAAD) surgery remains debated. Recent guidelines have advocated antegrade systemic perfusion through right axillary artery (RAX) cannulation, instead of femoral artery (FA) cannulation. However, RAX cannulation can be technically challenging and time-consuming. On the other hand, direct (ascending) aorta (DA) cannulation is a swift procedure that also ensures downstream antegrade flow. In this regard, we assessed whether DA cannulation is a safe alternative to FA cannulation.\u0000 Methods: Records of all patients undergoing ATAAD surgery between 2006-2022 at the Radboud University Medical Center were retrospectively reviewed.\u0000 Results: In total, 281 patients underwent surgery for ATAAD during the investigated period. Three patients were excluded due to death before the start of extracorporeal circulation and four because of RAX cannulation. Of the remaining 274 patients, 53% (N = 145) received primary FA and 47% (N = 129) DA cannulation, with a success rate of 98% for both approaches. Surgical mortality (combined in-hospital and 30-day) was 9.9% (7.8% DA group vs. 11.7% FA group, P = 0.271). New permanent neurological damage was seen in 10.9% vs. 6.9% (P = 0.248), respectively. In multivariate analysis, cannulation strategies were not significantly associated with surgical mortality nor postoperative new permanent neurological damage.\u0000 Conclusion: DA cannulation offers a safe and fast alternative to FA cannulation in ATAAD surgery. There were no significant differences in mortality and neurological complications. Future studies should focus on the differences between RAX and DA cannulation strategies on postoperative outcomes in ATAAD surgery.","PeriodicalId":75299,"journal":{"name":"Vessel plus","volume":" 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140222229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-13DOI: 10.20517/2574-1209.2023.123
A. Strangio, I. Leo, J. Sabatino, Margarita Brida, Chiara Siracusa, Nicole Carabetta, P. Zaffino, C. Critelli, Alessandro Laschera, M. Spadea, Daniele Torella, Pierre Sabouret, Salvatore De Rosa
Artificial intelligence (AI) is changing our clinical practice. This is particularly true in cardiology where the clinician is often required to handle a large amount of clinical, biological, and imaging data during decision making. In this context, AI can address the need for fast and accurate tools while reducing the burden on clinicians and improving the efficiency of healthcare systems. With this inevitable shift towards more automated and efficient systems, patients may benefit from a more accurate diagnosis and more tailored treatment. A multitude of clinical applications have already been made available and implemented in several fields of cardiology. The aim of this narrative review is to provide an overall picture of the most recent evidence in the literature about AI implementations, highlighting their potential impact on clinical practice.
{"title":"Is artificial intelligence the new kid on the block? Sustainable applications in cardiology","authors":"A. Strangio, I. Leo, J. Sabatino, Margarita Brida, Chiara Siracusa, Nicole Carabetta, P. Zaffino, C. Critelli, Alessandro Laschera, M. Spadea, Daniele Torella, Pierre Sabouret, Salvatore De Rosa","doi":"10.20517/2574-1209.2023.123","DOIUrl":"https://doi.org/10.20517/2574-1209.2023.123","url":null,"abstract":"Artificial intelligence (AI) is changing our clinical practice. This is particularly true in cardiology where the clinician is often required to handle a large amount of clinical, biological, and imaging data during decision making. In this context, AI can address the need for fast and accurate tools while reducing the burden on clinicians and improving the efficiency of healthcare systems. With this inevitable shift towards more automated and efficient systems, patients may benefit from a more accurate diagnosis and more tailored treatment. A multitude of clinical applications have already been made available and implemented in several fields of cardiology. The aim of this narrative review is to provide an overall picture of the most recent evidence in the literature about AI implementations, highlighting their potential impact on clinical practice.","PeriodicalId":75299,"journal":{"name":"Vessel plus","volume":"45 1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140245387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：